Michel Chevallard

Michel Chevallard

Auto-generated profile, based on publicly available information

Michel Chevallard

Division of Rheumatology, Multispecialist Medical Department, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

7 October 2022 in Clinical Rheumatology
Verified
Journal Article
Closed access
PDF file
MCMichel Chevallard
Michel Chevallard
AAAntonella Adinolfi
Antonella Adinolfi
LBLaura Belloli
Laura Belloli
CCCinzia Casu
Cinzia Casu
MCMaria Di Cicco
Maria Di Cicco
OEOscar Massimiliano Epis
Oscar Massimiliano Epis

7 August 2018 in Clinical and Molecular Allergy
Verified
Journal Article
Open access
PDF file
LLLaura M. Losappio
Laura M. Losappio
CMCorrado Mirone
Corrado Mirone
MCMichel Chevallard
Michel Chevallard
LFLaura Farioli
Laura Farioli
FLFabrizio De Luca
Fabrizio De Luca
EPElide A. Pastorello
Elide A. Pastorello
Severe aortic valve stenosis is one of the most common cause of mortality in adult patients affected with metabolic syndrome, a condition associated with an active inflammatory process involving also mast cells and their mediators, in particular tryptase. The aim of this study was to characterize the possible long-term prognostic role of tryptase in severe aortic valve stenosis. The baseline serum tryptase was measured in 5 consecutive patients admitted to our Hospital to undergo aortic valve replacement for severe acquired stenosis. Within 2 years after, the patients were evaluated for the occurrence of major cardiovascular events (MACE). The tryptase measurements were higher in patients experiencing MACE (10.9, 11.7 and 9.32 ng/ml) than in non-MACE ones (5.69 and 5.58 ng/ml). In patients affected with severe aortic stenosis, baseline serum tryptase may predict occurence of MACE. Further studies are needed to demonstrate the long-term prognostic role of this biomarker.

29 May 2021 in medRxiv
Verified
Preprint
Open access
PDF file
NUNicola Ughi
Nicola Ughi
AAAntonella Adinolfi
Antonella Adinolfi
MCMichel Chevallard
Michel Chevallard
LBLaura Belloli
Laura Belloli
MSMichele Senatore
Michele Senatore
OEOscar Massimiliano Epis
Oscar Massimiliano Epis
Background An urgent need exists for an early detection of cases with a high-risk of SARS-CoV-2 infection, particularly in high-flow and -risk settings, such as emergency departments (EDs). The aim of this work is to develop and validate a predictive model for the evaluation of SARS-CoV-2 infection risk, with the rationale of using this tool to manage ED patients. Methods A retrospective study was performed by cross-sectionally reviewing the electronical case records of patients admitted to Niguarda Hospital or referred to its ED in the period 15 March to 24 April 2020. Derivation sample was composed of non-random inpatients hospitalized on 24 April and admitted before 22 April 2020. Validation sample was composed of consecutive patients who visited the ED between 15 and 25 March 2020. The association between the dichotomic outcome and each predictor was explored by univariate analysis with logistic regression models. Results A total of 113 patients in the derivation sample and 419 in the validation sample were analyzed. History of fever, elder age and low oxygen saturation showed to be significant predictors of SARS-CoV-2 infection. The neutrophil count improves the discriminative ability of the model, even if its calibration and usefulness in terms of diagnosis is unclear. Conclusion The discriminatory ability of the identified models makes the overall performance suboptimal; their implementation to calculate the individual risk of infection should not be used without additional investigations. However, they could be useful to evaluate the spatial allocation of patients while awaiting the result of the nasopharyngeal swab. What is already known on this topic 1 year after the onset of the coronavirus disease 2019 (COVID-19) pandemic, the trend of its spread has not shown a substantial global reduction. An urgent need exists for efficient early detection of cases with a high risk of SARS-CoV-2 infection and a number of diagnostic prediction models have been developed, but a few models were externally validated in high-flow and –risk settings, such as emergency departments (EDs). What this study adds This study develops and validate predictive models for the evaluation of SARS-CoV-2 infection risk, with the rationale of using these tools to promptly manage patients who are afferent to the ED, allocating them accordingly to the risk of infection while awaiting swab result. History of fever, older age and low oxygen saturation showed to be significant predictors of the presence of SARS-CoV-2 infection. The use of laboratory findings, such as neutrophil count, showed to improve the discriminative ability of the model, even if its calibration and usefulness in terms of diagnosis is unclear.